Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare.
Journal
JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500
Informations de publication
Date de publication:
03 02 2023
03 02 2023
Historique:
entrez:
17
2
2023
pubmed:
18
2
2023
medline:
22
2
2023
Statut:
epublish
Résumé
Older adults in Medicare Advantage (MA) enroll in hospice at higher rates than those in traditional Medicare (TM), but it is unclear whether the pathway of care prior to hospice use differs between MA and TM. To examine the site of care prior to hospice enrollment for MA beneficiaries compared with those in TM. This population-based, retrospective cross-sectional study used Medicare claims data for decedents in calendar years 2011, 2013, 2016, and 2018 who enrolled in hospice in the last 90 days of life. Data were analyzed from February 11, 2022, to October 24, 2022. Enrollment in MA or TM in the last month of life. The main outcome was the site of care prior to hospice enrollment, defined as hospital, nursing home, and home with or without home health, dichotomized as community vs hospital in a logistic regression model. Covariates included decedent demographics, hospice primary diagnosis, and county-level MA penetration. Differences in hospice length of stay between MA beneficiaries and TM beneficiaries were assessed using linear and logistic regression models. In this study of 3 164 959 decedents, mean (SD) age was 83.1 (8.6) years, 55.8% were female, and 28.8% were enrolled in MA. Decedents in MA were more likely to enroll in hospice from a community setting than were those in TM, although the gap narrowed over time from an unadjusted 11.1% higher rate of community enrollment in MA vs TM in 2011 (50.1% vs 39.0%) to 8.1% in 2018 (46.4% vs 38.3%). In the primary adjusted analysis over the entire study period, MA enrollment was associated with an 8.09-percentage point (95% CI, 7.96-8.21 percentage points) higher rate of hospice enrollment from the community vs all other sites. This association remained in multiple sensitivity analyses to account for potential differences in the populations enrolled in MA vs TM. The mean overall hospice length of stay was 0.29 days (95% CI, 0.24-0.34 days) longer for MA decedents compared with TM decedents. Compared with TM beneficiaries, those in MA were more likely to enroll in hospice from community settings vs following inpatient stays. However, hospice length of stay was not substantially different between MA and TM. Further research is needed to understand how MA plans influence hospice use and the direct association with quality of end-of-life care as reported by older adults and their families.
Identifiants
pubmed: 36800194
pii: 2801476
doi: 10.1001/jamahealthforum.2022.5457
pmc: PMC9938424
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e225457Subventions
Organisme : NIA NIH HHS
ID : K76 AG064427
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG028741
Pays : United States
Références
J Am Geriatr Soc. 2011 Aug;59(8):1531-6
pubmed: 21797834
Med Care. 2020 Sep;58(9):805-814
pubmed: 32826746
J Am Geriatr Soc. 2018 Aug;66(8):1508-1514
pubmed: 30091240
JAMA. 2018 Jul 17;320(3):264-271
pubmed: 29946682
Health Care Financ Rev. 2008 Spring;29(3):27-42
pubmed: 18567241
Health Serv Res. 2022 Aug;57(4):863-871
pubmed: 35156205
JAMA Intern Med. 2018 Jun 1;178(6):792-799
pubmed: 29710217
JAMA Intern Med. 2016 Jul 1;176(7):1020-3
pubmed: 27273237
Med Care. 2020 Dec;58(12):1069-1074
pubmed: 32925461
JAMA Health Forum. 2021 Mar 1;2(3):e210235
pubmed: 36218457
Med Care. 2013 Oct;51(10):931-7
pubmed: 23969590
J Am Geriatr Soc. 2018 Feb;66(2):407-413
pubmed: 29250770
J Am Geriatr Soc. 2021 Oct;69(10):2802-2810
pubmed: 33989430
J Palliat Med. 2022 Nov;25(11):1661-1667
pubmed: 35549529
J Am Geriatr Soc. 2005 May;53(5):819-23
pubmed: 15877557
Health Aff (Millwood). 2013 Mar;32(3):552-61
pubmed: 23459735
Health Aff (Millwood). 2018 Jan;37(1):78-85
pubmed: 29309215
J Pain Symptom Manage. 2012 Apr;43(4):732-8
pubmed: 22285282
Health Serv Res. 2011 Feb;46(1 Pt 1):120-37
pubmed: 21029090
Health Econ. 2021 Feb;30(2):311-327
pubmed: 33219715
J Pain Palliat Care Pharmacother. 2010 Sep;24(3):302-5
pubmed: 20718654
JAMA Health Forum. 2022 Feb 11;3(2):e215104
pubmed: 35977281
Am J Manag Care. 2018 Dec 1;24(12):e386-e392
pubmed: 30586487
Health Aff (Millwood). 2017 Jan 1;36(1):91-100
pubmed: 28069851
JAMA Health Forum. 2022 Apr 1;3(4):e221113
pubmed: 36218964
Am J Hosp Palliat Care. 2017 Nov;34(9):860-868
pubmed: 27418598
J Pain Symptom Manage. 2007 Aug;34(2):120-5
pubmed: 17583469